What is the predictive value of the prognostic nutritional index for the severity of COVID-19 hospitalized patients ?
Abstract
risk assessment should be performed consistently and promptly to determine the proper nutritional therapy
and lead to a good prognosis. We aimed to investigate the predictive value of the prognostic nutritional index
(PNI) in determining the severity of hospitalized COVID-19 patients.
Methods: In this retrospective single-center research, a total of 686 hospitalized adult patients with COVID19 between April 2020-June 2020 were analyzed. Demographic, clinical, radiological and laboratory data
were registered from patient files. Nutritional status was evaluated using the BMI and PNI. Patients were
divided into three groups according to PNI values: severe (PNI ≤ 35), moderate (35(PNI≥38).
Results: The study group's average PNI score was 35.56 ± 4.58.PNI values were found to be normal in 37.3
percent (N: 256) of the patients, moderate in 28.3 percent (N: 194), and severe in 34.4 percent (N: 236). Male
patients, those over the age of 65, referred patients, intubated patients, and those who died were at a higher
risk of severe PNI. Patients with normal computed tomography scans were found to have a higher incidence
in the normal PNI. The length of hospitalization increased in proportion to the severity of PNI. As the severity
of the PNI category increased, so did albumin, C reactive protein, D-dimer, ferritin, lactate dehydrogenase,
and neutrophil levels. The total protein value decreased, as the severity of the PNI category increased.
Conclusion: PNI can be determined easily and quickly using routine blood tests and it can be useful for early
detection of potentially fatal illnesses, giving medical care and improving prognosis.
Keywords
COVID 19, malnutrition, Prognostic Nutritional Index, prognosis
References
- 1. World Health Organisation. Weekly epidemiological update on Coronavirus disease 2019. 21 December 2021.Available from:https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-21-december-2021
- 2. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet Lond Engl. 2020;395:1014–1015.
- 3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl. 2020; 395:497–506.
- 4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–9.
- 5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China descriptive study. Lancet Lond Engl. 2020;395:507–513.
- 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020;395:1054–1062.
- 7. Peter K. Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;May15;46(10):1582-1588.
- 8. Xue G, Gan X, Wu Z, Xie D, Xiong Y, Hua L et al. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19. Int Immunopharmacol.2020;89(Pt A): 107065.
- 9. Ahn SS, Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Comparison of the Clinical Implications among Five Different Nutritional Indices in Patients with Lupus Nephritis. Nutrients. 2019;11(7):1456.
- 10. Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients. 2020;19;12(5):1466.